Skip to content
LGBTQIA, Medical Health Aged Care

Dash Heath-Paynter confirmed as Health Equity Matters CEO

Health Equity Matter 2 mins read

Health Equity Matters, Australia’s HIV and LGBTIQA+ health federation, is pleased to announce the appointment of Dash Heath-Paynter as its new chief executive officer.

 

Dash takes on the leadership of Health Equity Matters after serving almost eight years as deputy CEO. During that period, Dash oversaw policy development, political advocacy and engagement. This encompassed the national community response to Mpox, including co-chairing the National Mpox Taskforce.

 

“We are delighted to confirm the appointment of Dash Heath-Paynter as our new chief executive,” Health Equity Matters President, Mark Orr AM, said. “Dash brings deep, sustained experience in HIV and LGBTIQA+ health advocacy and policy. Dash’s skills and experience will serve our communities well as we push for the virtual elimination of HIV transmission and a more robust community-led response to the health needs of LGBTIQA+ communities.”

 

Dash is a member of the Medical Services Advisory Committee (MSAC) PICO Advisory Sub-Committee (PASC); the Therapeutics Goods Administration (TGA) Advertising Consultative Committee, the National HIV PrEP Guidelines Committee and the National HIV Testing Policy Expert Reference Committee. 

 

“It is a profound honour and privilege to take on the executive leadership of the Health Equity Matters at this pivotal moment,” Dash Heath-Paynter said. “My predecessor, Adjunct Professor Darryl O’Donnell established strong foundations for us to make monumental progress towards better health responses for LGBTIQA+ people, the virtual elimination of HIV transmission and continuing support for people living with HIV. 

 

“We have an incredibly talented and motivated team at Health Equity Matters and we take seriously our role in protecting and promoting the partnership of researchers, clinicians, community and government that is at the centre of Australia’s HIV response.

 

“I look forward to working closely with the Federal Government to drive further progress for the communities we represent and serve.”

 

Prior to joining Health Equity Matters’ Dash worked as a senior policy analyst at Health Equity Matters’ Victorian member organisation, the Victorian AIDS Council, now Thorne Harbour Health.

 

Dash is an Adjunct Senior Lecturer at the Kirby Institute, at the University of New South Wales and holds degrees in law and arts. He is a graduate of the Harvard University Kennedy School of Government Executive Leadership Program.

 

Interview requests: Nick Lucchinelli 0422229032

 

More from this category

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

  • Medical Health Aged Care
  • 14/01/2025
  • 17:10
Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.